RETURN TO TOP

November 03, 2026

Why Updated Thyroid Nodule Risk Stratification Guidelines Matter

Written by: Jennifer Sipos MD


Click play button to watch video


Understanding the Limitations of Existing Systems

Thyroid nodules are commonly encountered in clinical practice, and ultrasound plays an essential role in their evaluation. For healthcare professionals performing and interpreting thyroid ultrasound examinations, assessing nodule characteristics helps determine which nodules may require further evaluation, follow-up, or fine-needle aspiration (FNA).

Several thyroid nodule risk stratification systems have been developed to help standardize these decisions. However, even widely used systems such as the American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) and American Thyroid Association (ATA) guidelines have recognized limitations.

In an episode of The Sonography Lounge, Dr. Jennifer Sipos discusses why updated thyroid nodule risk stratification guidance is needed, how existing systems differ, and one of the challenges clinicians face when evaluating thyroid nodules.

What Are Thyroid Nodule Risk Stratification Systems?

Thyroid nodule risk stratification systems use sonographic characteristics to estimate the likelihood of malignancy and guide clinical management.

During a thyroid ultrasound examination, healthcare professionals evaluate features such as nodule composition, echogenicity, shape, margins, and echogenic foci. These findings help determine a nodule’s risk category and whether biopsy or surveillance may be appropriate.

Common systems include ACR TI-RADS, ATA sonographic patterns, European TI-RADS (EU-TIRADS), and Korean TI-RADS (K-TIRADS). Their criteria and management thresholds differ, even though they share the goal of identifying clinically important nodules while limiting unnecessary procedures.

Why Are Updated Thyroid Ultrasound Guidelines Needed?

As Dr. Sipos explains in the podcast excerpt, existing thyroid nodule risk stratification systems generally perform well, but each has limitations. In particular, differences in fine-needle aspiration size thresholds influence how frequently nodules are recommended for biopsy and affect measures of diagnostic performance.

More aggressive biopsy thresholds can increase detection while also increasing procedures for benign nodules. More conservative thresholds can reduce unnecessary biopsies but require careful consideration of potentially significant findings. Effective guidance seeks to balance these priorities.

What Is One of the Biggest Limitations of the Previous ATA Classification System?

One important limitation discussed by Dr. Sipos involves thyroid nodules that do not fit neatly into the sonographic patterns in the previous ATA framework.

According to the podcast discussion, published research has reported that up to 20% of thyroid nodules may not be classifiable under the earlier ATA pattern-based system, although estimates vary by study and patient population. 

When a nodule does not fit an established risk category, determining the most appropriate management pathway can become more difficult. Addressing these classification gaps is one motivation for refining risk stratification guidance.

How Can Updated Risk Stratification Improve Thyroid Ultrasound Evaluation?

Improved classification criteria may support more consistent nodule categorization, clearer follow-up recommendations, better communication across specialties, and a more standardized approach to clinical decisions. The ultimate goal is to balance detection of clinically significant malignancy against unnecessary biopsy and surveillance.

As thyroid ultrasound guidance evolves, understanding the strengths and limitations of established systems remains important for healthcare professionals involved in nodule assessment.

Learn More About Thyroid Ultrasound with Gulfcoast Ultrasound Institute

Gulfcoast Ultrasound Institute offers Introduction to Thyroid Ultrasound education for healthcare professionals seeking to strengthen their understanding of thyroid anatomy, sonographic evaluation, scanning techniques, and thyroid pathology.

Introduction to Thyroid Ultrasound – Live Course: November 13, 2026, in St. Petersburg, Florida. The live format combines faculty-led education with hands-on scanning opportunities. 

Introduction to Thyroid Ultrasound – Virtual Conference: November 13, 2026. This option supports remote participation in thyroid ultrasound education. 

With both course options approaching, now is a timely opportunity to expand thyroid ultrasound knowledge and review evolving clinical guidance.

Continue the Conversation with The Sonography Lounge

Watch or listen to the full podcast episode for more context on the limitations of existing thyroid nodule classification systems and the rationale for updated guidance.



   Introduction to Thyroid Ultrasound – Live Course

   Introduction to Thyroid Ultrasound – Virtual Conference

   Spotify


 

About the Author

Jennifer Sipos MD


Dr. Jennifer A. Sipos is a Professor of Medicine at the Ohio State University. She also serves as the Medical Director of the Neuroendocrine Cancer Program at The Arthur G. James Comprehensive Cancer Center. She obtained her medical degree and Internal Medicine residency training at Wake Forest University. She completed her Endocrinology and Metabolism Fellowship at the University of North Carolina in Chapel Hill. Dr. Sipos has developed an interest in the use of ultrasonography for the diagnosis and management of thyroid nodules and cancer and has taught and served as a course director for numerous ultrasound courses nationally and internationally. Additionally, she is actively involved in several clinical research projects with a particular interest in factors implicated in the development of salivary damage after radioiodine therapy. She also participates in clinical trials for the evaluation of multikinase inhibitor therapies in refractory thyroid cancer and the diagnostic use of molecular markers in thyroid nodules. She is an invited member of the International Thyroid Nodule Ultrasound Working Group to create an evidence-based guideline for a unified system of thyroid nodule risk stratification and management. Additionally, she is a member of the writing task force for the Thyroid Nodule Guidelines sponsored by the American Thyroid Association. She is also a member of the Thyroid Carcinoma Panel of the NCCN Clinical Practice Guidelines.

View Author's Courses

41 YEARS

Serving the Medical Community

200,000+

Participants Trained

500,000+

CME Credits Awarded

6,000+

Courses Offered

CONFIDENCE, COMPETENCE, PROVEN RESULTS

(727) 353-8222 - Google Ads